United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$33Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $4.6M sold, first sale Apr 2025
Bios PartnersLead
Correlation Ventures
Hatteras Venture Partners
Aju IB Investment
Access Industries
ExSight Ventures
InFocus Capital PartnersReported by Hatteras Venture PartnersSEC filing: $11M sold, first sale Jul 2019
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Trefoil Therapeutics's investors include Correlation Ventures, Hatteras Venture Partners, Bios Partners, National Institutes of Health and Aju IB Investment, and 3 more on record.
Trefoil Therapeutics has raised $33M across 2 rounds since 2019.
Trefoil Therapeutics's most recent round was a Venture of $4.6M in May 2025.
Trefoil Therapeutics's largest round on record is $28M (Series A), in Jul 2019, led by Bios Partners.
Trefoil Therapeutics's first round on record, in Jul 2019, was backed by Bios Partners, Correlation Ventures and Hatteras Venture Partners and 4 others.
Trefoil Therapeutics's latest named round is a Venture, in May 2025.
Trefoil Therapeutics is based in the United States.
Bios Partners led the Series A in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
